Skip to main content
University of California San Francisco
UCSF Health
Search UCSF
About UCSF
Search form
Search...
Twitter
About
Outreach
Vision
Neuroscience Program Bylaws
DEI
Admissions
Application Process
Other Considerations
Frequently Asked Questions
Graduate Student Fair
Current Students
Student Handbook
1st Year Student Companion Guide
2nd Year Student Companion Guide
3rd Year+ Student Companion Guide
Quals Handbook Companion Guide_2021
Forms
Additional Resources
Curriculum
Course List
UCSF Course Catalog
Study List Filing Info
UCSF Academic Calendar
Faculty
Events
Annual Retreat
Formal Seminar Series
External Postdoc Seminar Program (EPSP)
Neuroscience Program and Community Calendar
RIPS
Kavli Faculty Seminar
Contact
You are here
Home
>
Alzheimer's & Dementia
Alzheimer's & Dementia
Predictive Modeling Leveraging Electronic Health Records Identifies Early Predictors of Alzheimer’s Disease.
Plasma rejuvenation factor GDF11 associates with amyloid-related cognitive decline in older adults across the Alzheimer’s Disease spectrum.
Phospholipase D3 drives microglial response to amyloid pathology in Alzheimer’s disease.
Multiomics of iPSC-derived ApoE3- and ApoE4 astrocytes and microglia uncovers cell type specific dysregulation of immunometabolism.
Alzheimer’s disease risk genes modulate interferon-responsive microglia.
Relationships between KLOTHO and APOE4-associated ß-amyloid and tau alterations across AD continuum.
Klotho protein concentrations as a function of sex, APOE, family history or Alzheimer’s disease biomarker status in an at-risk cohort.
Pathological Validation of RORB and CDH9 as Selectively Vulnerable Neurons in Alzheimer’s Disease.
The Lonafarnib target, Rhes, is uniquely dysregulated in tauopathies: A human postmortem study.
TAU-MEDIATED CELL DEATH MECHANISMS IN MAPT V337M IPSC-DERIVED HUMAN NEURONS.
Pages
1
2
3
next ›
last »